Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Regulatory News (APH)

  • This share is currently suspended. It was suspended at a price of 64.70
  • There is currently no data for APH

Form 8.3 ALLIANCE PHARMA PLC

17 Apr 2025 13:22

RNS Number : 5088F
Barclays PLC
17 April 2025
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

 

Barclays PLC.

(b)

Owner or controller of interest and short

 

 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

ALLIANCE PHARMA PLC

 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

 

 

offeror/offeree, state this and specify identity of

 

offeror/offeree:

(e)

Date position held/dealing undertaken:

16 Apr 2025

(f)

In addition to the company in 1(c) above, is the discloser making

NO

 

 

 

disclosures in respect of any other party to the offer?

 

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

 

 

to which the disclosure relates following the dealing(if any)

 

Class of relevant security:

1p ordinary

 

Interests

Short Positions

 

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

 

and/or controlled:

 

 

5,741,923

1.06%

1,956,258

0.36%

(2)

Cash-settled derivatives:

 

 

 

 

 

and/or controlled:

 

 

1,063,873

0.20%

5,741,834

1.06%

(3)

Stock-settled derivatives (including options)

 

 

 

 

 

and agreements to purchase/sell:

 

 

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

 

TOTAL:

 

 

6,805,796

1.26%

7,698,092

1.42%

(b)

Rights to subscribe for new securities (including directors and other executive

 

 

options)

 

 

 

 

 

 

Class of relevant security in relation to

 

 

 

 

which subscription right exists

 

 

 

 

Details, including nature of the rights

 

 

 

 

concerned and relevant percentages:

 

 

 

 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

 

 

 

 

 

Class of relevant

Purchase/sale

Number of

Price per unit

security

 

securities

 

1p ordinary

Purchase

39,648

0.6420 GBP

1p ordinary

Purchase

14,994

0.6430 GBP

1p ordinary

Sale

43,918

0.6424 GBP

1p ordinary

Sale

35,540

0.6420 GBP

1p ordinary

Sale

14,951

0.6419 GBP

 

 

 

 

 

 

 

 

(b)

Cash-settled derivative transactions

 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

 

reference

unit

security

 

 

securities

 

1p ordinary

SWAP

Decreasing Short

12,863

0.6419 GBP

1p ordinary

SWAP

Decreasing Short

23,698

0.6420 GBP

1p ordinary

SWAP

Decreasing Short

42,076

0.6424 GBP

1p ordinary

SWAP

Increasing Short

25,538

0.6420 GBP

1p ordinary

SWAP

Increasing Short

14,994

0.6430 GBP

 

 

 

 

 

 

 

 

(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

 

date

money

relevant

 

selling,

securities

per unit

 

 

paid/

security

 

varying etc

to which

 

 

 

received

 

 

 

option

 

 

 

per unit

 

 

 

relates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)

Exercising

 

 

 

 

 

 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

 

 

securities

unit

 

 

 

 

 

 

 

 

 

 

 

 

 

(d)

Other dealings (including subscribing for new securities)

 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

 

 

applicable)

 

 

 

 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

 

 

formal or informal, relating to relevant securities which may be an inducement to deal

 

 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

 

to the offer or any person acting in concert with a party to the offer:

 

 

 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

 

 

the person making the disclosure and any other person relating to:

 

 

(i) the voting rights of any relevant securities under any option; or

 

 

 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

 

 

any derivative is referenced:

 

 

 

 

 

 

NONE

(c)

Attachments

 

 

 

 

 

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

17 Apr 2025

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETIRMBTMTABBBA
Date   Source Headline
21st Aug 20158:45 amRNSExercise of Share Options
17th Aug 20157:00 amRNSNotification of Interim Results
13th Jul 20157:00 amRNSPre-Close Trading Update
10th Jul 20157:00 amRNSAppointment of Finance Director
23rd Jun 20151:30 pmRNSDirector Shareholding
17th Jun 20155:30 pmRNSDirector Shareholding
1st Jun 20153:30 pmRNSExercise of Share Options
27th May 20152:00 pmRNSShare Options
27th May 20157:00 amRNSAGM Statement
20th Apr 20157:00 amRNSHardman & Co issues research report
15th Apr 20157:00 amRNSExercise of Share Options
10th Apr 20157:00 amRNSAnnual Report and AGM Notice
25th Mar 20157:00 amRNSPreliminary Results
3rd Mar 20159:30 amRNSExercise of Share Options
17th Feb 20157:00 amRNSDirectorate Change
16th Feb 20157:00 amRNSNotification of Preliminary Results
2nd Feb 201512:15 pmRNSAcquisition of MacuVision
26th Jan 20157:00 amRNSAppointment of Non-Executive Director
19th Jan 20157:00 amRNSPre-Close Trading Update
18th Dec 20143:27 pmRNSDirectorate Change
10th Sep 20147:00 amRNSAlliance Pharma PLC Interim Results
5th Aug 20147:00 amRNSNotification of Interim Results
9th Jul 20147:00 amRNSPre-Close Trading Update
19th Jun 20145:35 pmRNSExercise of Share Options
21st May 20147:00 amRNSAGM Statement
11th Apr 20142:30 pmRNSShare Options
11th Apr 20147:00 amRNSMajor Interest in Shares
10th Apr 20142:57 pmRNSExercise of Share Options
10th Apr 20147:00 amRNSAnnual Report and Notice of AGM
7th Apr 20142:45 pmRNSTR-1: Notification of Major Interest in Shares
1st Apr 20147:00 amRNSAppointment of Non-Executive Director
26th Mar 20147:00 amRNSPreliminary Results
4th Feb 20147:00 amRNSNotification of Preliminary Results
23rd Jan 20149:30 amRNSTR-1: Notification of Major Interest in Shares
20th Jan 20147:00 amRNSDirector Shareholding
14th Jan 20147:00 amRNSAcquisition in Germany
14th Jan 20147:00 amRNSPre-Close Trading Update
30th Dec 20132:00 pmRNSDirectorate Change
19th Dec 20132:45 pmRNSCULS Conversion and Additional Listing
18th Dec 20137:00 amRNSAcquisition of Lypsyl
9th Dec 20137:00 amRNSMajor Interest in Shares
2nd Dec 20136:00 pmRNSCULS Conversion and Additional Listing
11th Nov 20134:20 pmRNSCULS Conversion and Additional Listing
7th Nov 20131:46 pmRNSCompulsory Conversion of CULS
28th Oct 20133:01 pmRNSCULS Conversion and Additional Listing
25th Oct 20138:00 amRNSMajor Interest in Shares
24th Oct 20135:55 pmRNSShare Options
22nd Oct 20139:30 amRNSCULS Conversion and Additional Listing
11th Oct 20137:00 amRNS£55 Million Bank Facilities
16th Sep 20132:01 pmRNSCULS Conversion and Additional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.